Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0001727794-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2025-12-31 | YARW | Domzalski David | Pres AND CEO, Dir | F - Tax | $0.58 | -12.7K | 416.2K | -3% | -$7,357 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | F | D | 12,684 | $0.58 | 416,208 | D | — | — |